Critical Care Therapeutics Market by Drug Class and Geography - Forecast and Analysis 2021-2025

  • Published: Jan 2021
  • Pages: 120
  • SKU: IRTNTR46526
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The critical care therapeutics market size has the potential to grow by USD 888.68 million during 2021-2025, and the market’s growth momentum will decelerate at a CAGR of 5.08%. 

This report provides a detailed analysis of the market by drug class (albumin, antithrombin concentrates, prothrombin complex concentrates, factor XIII concentrates, and fibrinogen concentrates), geography (Asia, Europe, North America, and ROW), and key vendors. 

Market Overview

Critical-Care-Therapeutics-Market-Market-Size-2020-2025

Browse TOC and LoE with selected illustrations and example pages of Critical Care Therapeutics Market 

Request a FREE sample now!

Market Competitive Analysis

The report analyzes the market’s competitive landscape and offers information on several market vendors, including: 

 

  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • CSL Ltd.
  • Grifols SA
  • Kedrion Spa
  • LFB SA
  • Novartis AG
  • Octapharma AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.

 

The critical care therapeutics market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

The market players also significantly leverage external market drivers such as increasing surgical procedures to achieve growth opportunities. However, factors such as the spread of pathogenic contaminants will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the critical care therapeutics market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

This critical care therapeutics market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities. 

Critical Care Therapeutics Market: Key Drivers and Trends

  • The high demand for albumin in China will fuel the growth of the critical care therapeutics market size.
  • China is the largest market for albumin products, followed by the US market.
  • Albumin is being used as a volume replacement therapy apart from being used for kidney diseases, cirrhosis, and cancer.
  • The demand for plasma products, especially albumin and immunoglobulins, is outstripping the supply. This is because of the stringent regulations imposed on the supply of raw materials and a ban on the import of plasma products.
  • The vast difference in demand and supply is enabling the top players to enhance the prices of the products, and thus increase the revenues and contribute to the growth of the market. 
  • The increasing surgical procedures will also contribute to the critical care therapeutics market growth.
  • The increasing surgical procedures such as hip and knee replacements will increase the risk of DVT, driving the market growth.
  • Surgeries often result in long periods of immobility, increasing the chances of developing DVT due to reduced blood flow.
  • Individuals undergoing knee replacement and hip replacement surgeries have an increased likelihood of developing DVT.
  • It is also observed that cases of joint replacements and cardiovascular procedures are more commonly observed among the elderly population.
  • The increasing number of surgical procedures will drive the chances of developing thromboembolic events post surgeries, requiring treatment using anticoagulants. 

 

Grab your Free Sample now to unlock further information on other key market drivers

 

Critical Care Therapeutics Market: Segmentation by Geography

Critical-Care-Therapeutics-Market-Market-Share-by-Region-2020-2025

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market’s growth will originate from North America during the forecast period. The US is a key market for critical care therapeutics in North America. However, market growth in this region will be slower than the growth of the market in Asia.

The growing investments in the US healthcare industry will facilitate the critical care therapeutics market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report. 

Critical Care Therapeutics Market: Segmentation by Drug Class

Critical-Care-Therapeutics-Market-Market-Share-by-Drug Class-2020-2025

Request for a FREE sample and Get more information on the market contribution of various segments

The albumin segment of the market is expected to witness steady growth during the forecast period, owing to the high demand for albumin therapeutics in Asian countries such as China and India. Also, the increased exploitation of albumin in new therapeutic areas, along with the use for non-therapeutic purposes, is driving the critical care therapeutics market. The critical care therapeutics market share growth by the albumin segment will be faster than the prothrombin complex concentrates, antithrombin concentrates, factor XIII concentrates, and fibrinogen concentrates segments.    

This report provides an accurate prediction of the contribution of all the segments to the growth of the critical care therapeutics market size. Fetch actionable market insights on post COVID-19 impact on each segment.   

 

Event-Tickets-Market-Report

Request for a FREE sample

Critical Care Therapeutics Market: Key Highlights of the Report for 2021-2025

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive critical care therapeutics market growth during the next five years
  • Precise estimation of the critical care therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the critical care therapeutics industry across Asia, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of critical care therapeutics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Fiver forces analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by drug class

    • Market segments
    • Comparison by Drug class
    • Albumin - Market size and forecast 2020-2025
    • Antithrombin concentrates - Market size and forecast 2020-2025
    • Prothrombin complex concentrates - Market size and forecast 2020-2025
    • Factor XIII concentrates - Market size and forecast 2020-2025
    • Fibrinogen concentrates - Market size and forecast 2020-2025
    • Market opportunity by Drug class

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2020-2025
      • Europe - Market size and forecast 2020-2025
      • Asia - Market size and forecast 2020-2025
      • ROW - Market size and forecast 2020-2025
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Vendor landscape
      • Landscape disruption
      • Industry risks
      • Competitive scenario

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Baxter International Inc.
      • Bristol-Myers Squibb Co.
      • CSL Ltd.
      • Grifols SA
      • Kedrion Spa
      • LFB SA
      • Novartis AG
      • Octapharma AG
      • Pfizer Inc.
      • Takeda Pharmaceutical Co. Ltd.

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your FREE sample now!
      The critical care therapeutics market growth will increase by $888.68 million during 2020-2025.
      The critical care therapeutics market is expected to grow at a CAGR of 5.08% during 2020-2025.
      Technavio has segmented the critical care therapeutics market by other1 (Albumin, Antithrombin concentrates, Prothrombin complex concentrates, Factor XIII concentrates, and Fibrinogen concentrates) and geographic (North America, Europe, Asia, and ROW).
      Baxter International Inc., Bristol-Myers Squibb Co., CSL Ltd., Grifols SA, Kedrion Spa, LFB SA, Novartis AG, Octapharma AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd. are a few of the key vendors in the critical care therapeutics market.
      North America will register the highest growth rate of 39.43% among the other regions. Therefore, the critical care therapeutics market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
      The key factors driving the critical care therapeutics market growth are:
      • High demand for albumin in China
      The critical care therapeutics market vendors should focus on grabbing business opportunities from the albumin segment as it accounted for the largest market share in the base year.
      Safe and Secure SSL Encrypted
      Technavio

      Single User:

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Want to customize this report?

      This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

      We offer $1000 worth of FREE customization at the time of purchase
      Technavio
      Enquire Before Buying
      1. Home
      2. Health Care
      3. Published Report
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>